Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 30 Jan 2026 | 33 | 30% | 66% | 4% | 70% |
| 01 Jan 2025 - 30 Jun 2025 | 31 Jul 2025 | 34 | 29% | 66% | 5% | 71% |
| 01 Jul 2024 - 31 Dec 2024 | 22 Jan 2025 | 34 | 35% | 59% | 6% | 65% |
| 01 Jan 2024 - 30 Jun 2024 | 19 Jul 2024 | 35 | 27% | 66% | 7% | 73% |
| 01 Jul 2023 - 31 Dec 2023 | 29 Jan 2024 | 34 | 29% | 65% | 6% | 71% |
| 01 Jan 2023 - 30 Jun 2023 | 27 Jul 2023 | 34 | 26% | 68% | 6% | 74% |
| 01 Jul 2022 - 31 Dec 2022 | 30 Jan 2023 | 34 | 29% | 66% | 5% | 71% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 34 | 29% | 65% | 6% | 71% |
| 01 Jul 2021 - 31 Dec 2021 | 31 Jan 2022 | 32 | 27% | 67% | 6% | 73% |
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 35 | 28% | 66% | 6% | 72% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 37 | 33% | 60% | 7% | 67% |
| 01 Jan 2020 - 30 Jun 2020 | 14 Jul 2020 | 35 | 27% | 67% | 6% | 73% |
| 01 Aug 2019 - 31 Dec 2019 | 30 Jan 2020 | 37 | 29% | 62% | 8% | 70% |
| 01 Jul 2018 - 31 Dec 2018 | 30 Jan 2019 | 37 | 28% | 56% | 16% | 72% |
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 39 | 27% | 51% | 22% | 73% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
We strive to make payment to our third party suppliers within 30 days. This is controlled via supplier master data held within our SAP system.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
Given that our business makes weekly BACS payment runs, there are a large volume of payments that are received by suppliers within 5 days of our 30 day target. Taking this factor into account, the percentage of invoices that were paid outside the target of 30 days would reduce from 70% to c. 36% in this reporting period (along with a corresponding significant reduction in the value). Our system records only the date stated on the invoice, the date the invoice is approved for payment; and the payment date itself. Our SAP system does not record the date the invoice is physically received. We have based our measurements on the stated invoice date, and on the assumption that all suppliers have 30 day payment terms. We have therefore been prudent in this report.
Maximum contractual payment period agreed
60
Invoice queries are usually raised either on management review (via a web-based invoice approval portal), or due to discrepancies between invoices and our purchase order (system based control). In either case, or Accounts Payable/Purchasing teams will discuss with suppliers on a case by case basis to reach a resolution. There is no fixed timescale target, however a report of blocked invoices is reviewed weekly to identify issues that need to be escalated. We have not adjusted our late payment statistics for disputed invoices, so again have taken a prudent position.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
B. Braun Medical Limited is registered in the UK under the SIC code for other human health activities and is tagged within the medical devices and instruments field. Evidence from a healthcare conference website shows the company operates Aesculap Academia, described as "part of B. Braun Medical Ltd", which supports medical education activities such as the BAHNO Annual Scientific Meeting for head and neck oncology professionals. This indicates the entity's role includes running or supporting clinical training and professional development programmes for healthcare specialists, alongside its broader classification within life sciences and medical technology. No further detail on manufacturing, distribution or product ranges is available from the supplied evidence.
Generated from the company's website and Companies House records. Sources: bahnomeeting.com